Skip to content

Modified internal limiting membrane occlusion for macular hole

Modified internal limiting membrane occlusion for macular hole

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068411
Enrollment
Unknown
Registered
2023-02-17
Start date
2021-05-14
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole

Interventions

control group:internal limiting membrane flap inversion
Experimental group:nternal limiting membrane flap forward

Sponsors

Xuzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with idiopathic macular hole by OCT.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of ocular trauma or intraocular surgery (such as vitrectomy, retinal cryotherapy, retinal laser therapy, etc.); 2. Patients with other intraocular diseases other than cataracts such as glaucoma, uveophthalmia or other fundus diseases , such as proliferative diabetic retinopathy, retinal detachment, wet age-related macular degeneration, etc.; 3. Patients with severe systemic organic diseases who cannot tolerate surgery; 4. Those who cannot keep face down after surgery.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity;hiatus healing rate;

Secondary

MeasureTime frame
Degree of visual distortion;Degree of contraction of the internal limiting membrane flap;retinal structural integrity;

Countries

China

Contacts

Public ContactLiu Haiyang

Xuzhou First People's Hospital

liuhaiyang86@126.com+86 136 8516 7216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026